A citation-based method for searching scientific literature

Michail Ignatiadis, George W Sledge, Stefanie S Jeffrey. Nat Rev Clin Oncol 2021
Times Cited: 152







List of co-cited articles
821 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
K C Allen Chan, John K S Woo, Ann King, Benny C Y Zee, W K Jacky Lam, Stephen L Chan, Sam W I Chu, Constance Mak, Irene O L Tse, Samantha Y M Leung,[...]. N Engl J Med 2017
310
4

Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation.
Peiyong Jiang, Kun Sun, Wenlei Peng, Suk Hang Cheng, Meng Ni, Philip C Yeung, Macy M S Heung, Tingting Xie, Huimin Shang, Ze Zhou,[...]. Cancer Discov 2020
41
9

Tumour heterogeneity and resistance to cancer therapies.
Ibiayi Dagogo-Jack, Alice T Shaw. Nat Rev Clin Oncol 2018
4

Neoplastic characteristics of the DNA found in the plasma of cancer patients.
M Stroun, P Anker, P Maurice, J Lyautey, C Lederrey, M Beljanski. Oncology 1989
486
4

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.
Mariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, Giorgio Corti, Giovanni Crisafulli, Leanne G Ahronian, Benedetta Mussolin, Eunice L Kwak, Michela Buscarino, Luca Lazzari,[...]. Cancer Discov 2016
251
4

Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Giovanna Rossi, Michail Ignatiadis. Cancer Res 2019
74
5

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.
J Tie, I Kinde, Y Wang, H L Wong, J Roebert, M Christie, M Tacey, R Wong, M Singh, C S Karapetis,[...]. Ann Oncol 2015
362
4

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
Huiyan Luo, Qi Zhao, Wei Wei, Lianghong Zheng, Shaohua Yi, Gen Li, Wenqiu Wang, Hui Sheng, Hengying Pu, Haiyu Mo,[...]. Sci Transl Med 2020
109
4

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Andrea Sartore-Bianchi, Benedetta Mussolin, Andrea Cassingena, Cosimo Martino, Richard B Lanman, Rebecca J Nagy, Stephen Fairclough,[...]. Cancer Cell 2018
73
5

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
Natasha B Leighl, Ray D Page, Victoria M Raymond, Davey B Daniel, Stephen G Divers, Karen L Reckamp, Miguel A Villalona-Calero, Daniel Dix, Justin I Odegaard, Richard B Lanman,[...]. Clin Cancer Res 2019
214
4

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Philip C Mack, Kimberly C Banks, Carin R Espenschied, Rebekah A Burich, Oliver A Zill, Christine E Lee, Jonathan W Riess, Stefanie A Mortimer, AmirAli Talasaz, Richard B Lanman,[...]. Cancer 2020
49
8

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.
Michael L Cheng, Eirini Pectasides, Glenn J Hanna, Heather A Parsons, Atish D Choudhury, Geoffrey R Oxnard. CA Cancer J Clin 2021
37
10

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Hitendra Patel, Ryosuke Okamura, Paul Fanta, Charmi Patel, Richard B Lanman, Victoria M Raymond, Shumei Kato, Razelle Kurzrock. J Hematol Oncol 2019
35
11

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Zhijie Wang, Jianchun Duan, Shangli Cai, Miao Han, Hua Dong, Jun Zhao, Bo Zhu, Shuhang Wang, Minglei Zhuo, Jianguo Sun,[...]. JAMA Oncol 2019
240
4

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
Angela Alama, Simona Coco, Carlo Genova, Giovanni Rossi, Vincenzo Fontana, Marco Tagliamento, Maria Giovanna Dal Bello, Alessandra Rosa, Simona Boccardo, Erika Rijavec,[...]. J Clin Med 2019
21
19

Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab.
Rajiv Raja, Michael Kuziora, Philip Z Brohawn, Brandon W Higgs, Ashok Gupta, Phillip A Dennis, Koustubh Ranade. Clin Cancer Res 2018
99
4

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.
Oliver A Zill, Claire Greene, Dragan Sebisanovic, Lai Mun Siew, Jim Leng, Mary Vu, Andrew E Hendifar, Zhen Wang, Chloe E Atreya, Robin K Kelley,[...]. Cancer Discov 2015
160
4

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
Peter Peneder, Adrian M Stütz, Didier Surdez, Manuela Krumbholz, Sabine Semper, Mathieu Chicard, Nathan C Sheffield, Gaelle Pierron, Eve Lapouble, Marcus Tötzl,[...]. Nat Commun 2021
23
17

Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients.
Nadine Van Roy, Malaïka Van Der Linden, Björn Menten, Annelies Dheedene, Charlotte Vandeputte, Jo Van Dorpe, Geneviève Laureys, Marleen Renard, Tom Sante, Tim Lammens,[...]. Clin Cancer Res 2017
66
6

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Barzin Y Nabet, Mohammad S Esfahani, Everett J Moding, Emily G Hamilton, Jacob J Chabon, Hira Rizvi, Chloe B Steen, Aadel A Chaudhuri, Chih Long Liu, Angela B Hui,[...]. Cell 2020
84
4

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Aadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, Aaron M Newman, Henning Stehr, Tej D Azad, Michael S Khodadoust, Mohammad Shahrokh Esfahani, Chih Long Liu, Li Zhou,[...]. Cancer Discov 2017
377
4

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
M J M Magbanua, L B Swigart, H-T Wu, G L Hirst, C Yau, D M Wolf, A Tin, R Salari, S Shchegrova, H Pawar,[...]. Ann Oncol 2021
49
8

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Viktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, Atish D Choudhury, Daniel G Stover, Heather A Parsons, Gregory Gydush, Sarah C Reed, Denisse Rotem, Justin Rhoades,[...]. Nat Commun 2017
316
4

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
4

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.
Bradon R McDonald, Tania Contente-Cuomo, Stephen-John Sammut, Ahuva Odenheimer-Bergman, Brenda Ernst, Nieves Perdigones, Suet-Feung Chin, Maria Farooq, Rosa Mejia, Patricia A Cronin,[...]. Sci Transl Med 2019
99
4

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
619
4

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, N Lopez-Bigas, C K Y Ng, P L Bedard, G Tortora, J-Y Douillard,[...]. Ann Oncol 2018
173
4

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
F André, E M Ciruelos, D Juric, S Loibl, M Campone, I A Mayer, G Rubovszky, T Yamashita, B Kaufman, Y-S Lu,[...]. Ann Oncol 2021
72
5

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Yoshito Komatsu, Yasuyuki Kawamoto, Naoki Takahashi,[...]. Nat Med 2020
75
5

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.
Christian Rolfo, Philip Mack, Giorgio V Scagliotti, Charu Aggarwal, Maria E Arcila, Fabrice Barlesi, Trever Bivona, Maximilian Diehn, Caroline Dive, Rafal Dziadziuszko,[...]. J Thorac Oncol 2021
50
8

Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
Adrian G Sacher, Cloud Paweletz, Suzanne E Dahlberg, Ryan S Alden, Allison O'Connell, Nora Feeney, Stacy L Mach, Pasi A Jänne, Geoffrey R Oxnard. JAMA Oncol 2016
396
4

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
W Jeffrey Allard, Jeri Matera, M Craig Miller, Madeline Repollet, Mark C Connelly, Chandra Rao, Arjan G J Tibbe, Jonathan W Uhr, Leon W M M Terstappen. Clin Cancer Res 2004
4

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.
David T Miyamoto, Richard J Lee, Mark Kalinich, Joseph A LiCausi, Yu Zheng, Tianqi Chen, John D Milner, Erin Emmons, Uyen Ho, Katherine Broderick,[...]. Cancer Discov 2018
75
5

Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
Massimo Cristofanilli, G Thomas Budd, Matthew J Ellis, Alison Stopeck, Jeri Matera, M Craig Miller, James M Reuben, Gerald V Doyle, W Jeffrey Allard, Leon W M M Terstappen,[...]. N Engl J Med 2004
4

Isolation of rare circulating tumour cells in cancer patients by microchip technology.
Sunitha Nagrath, Lecia V Sequist, Shyamala Maheswaran, Daphne W Bell, Daniel Irimia, Lindsey Ulkus, Matthew R Smith, Eunice L Kwak, Subba Digumarthy, Alona Muzikansky,[...]. Nature 2007
4

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.
A K Krug, D Enderle, C Karlovich, T Priewasser, S Bentink, A Spiel, K Brinkmann, J Emenegger, D G Grimm, E Castellanos-Rizaldos,[...]. Ann Oncol 2018
100
4

Neutrophils escort circulating tumour cells to enable cell cycle progression.
Barbara Maria Szczerba, Francesc Castro-Giner, Marcus Vetter, Ilona Krol, Sofia Gkountela, Julia Landin, Manuel C Scheidmann, Cinzia Donato, Ramona Scherrer, Jochen Singer,[...]. Nature 2019
425
4

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Mol Cancer 2019
98
4

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.
Christian Rolfo, Philip C Mack, Giorgio V Scagliotti, Paul Baas, Fabrice Barlesi, Trever G Bivona, Roy S Herbst, Tony S Mok, Nir Peled, Robert Pirker,[...]. J Thorac Oncol 2018
317
4


Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA.
Shu Yi Shen, Justin M Burgener, Scott V Bratman, Daniel D De Carvalho. Nat Protoc 2019
44
9

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Pier Vitale Nuzzo, Jacob E Berchuck, Keegan Korthauer, Sandor Spisak, Amin H Nassar, Sarah Abou Alaiwi, Ankur Chakravarthy, Shu Yi Shen, Ziad Bakouny, Francesco Boccardo,[...]. Nat Med 2020
68
5

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.
Thomas Reinert, Lone V Schøler, Rune Thomsen, Heidi Tobiasen, Søren Vang, Iver Nordentoft, Philippe Lamy, Anne-Sofie Kannerup, Frank V Mortensen, Katrine Stribolt,[...]. Gut 2016
261
4

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.
Leticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, Britta Weigelt, Francisco Martínez-Ricarte, Davis Torrejon, Mafalda Oliveira, Alexandra Arias, Carolina Raventos, Jiabin Tang,[...]. Nat Commun 2015
394
4


Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, Sinja Taavitsainen, Kevin Beja, Evan W Warner, Katherine Sunderland, Christian Kollmannsberger, Bernhard J Eigl, Daygen Finch,[...]. Cancer Discov 2018
246
4

Detection and quantification of rare mutations with massively parallel sequencing.
Isaac Kinde, Jian Wu, Nick Papadopoulos, Kenneth W Kinzler, Bert Vogelstein. Proc Natl Acad Sci U S A 2011
730
4

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
4

A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer.
Tanya T Kwan, Aditya Bardia, Laura M Spring, Anita Giobbie-Hurder, Mark Kalinich, Taronish Dubash, Tilak Sundaresan, Xin Hong, Joseph A LiCausi, Uyen Ho,[...]. Cancer Discov 2018
49
6

The pre-analytical phase of the liquid biopsy.
Francesca Salvianti, Stefania Gelmini, Filomena Costanza, Irene Mancini, Gemma Sonnati, Lisa Simi, Mario Pazzagli, Pamela Pinzani. N Biotechnol 2020
25
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.